AAAAAA

   
Results: 1-25 |
Results: 25
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
Authors: Fisher, B Dignam, J Bryant, J Wolmark, N
Citation: B. Fisher et al., Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial, J NAT CANC, 93(9), 2001, pp. 684-690
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
Authors: Fisher, B Dignam, J Tan-Chiu, E Anderson, S Fisher, ER Wittliff, JL Wolmark, N
Citation: B. Fisher et al., Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes, J NAT CANC, 93(2), 2001, pp. 112-120
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23
Authors: Fisher, B Anderson, S Tan-Chiu, E Wolmark, N Wickerham, DL Fisher, ER Dimitrov, NV Atkins, JN Abramson, N Merajver, S Romond, EH Kardinal, CG Shibata, HR Margolese, RG Farrar, WB
Citation: B. Fisher et al., Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23, J CL ONCOL, 19(4), 2001, pp. 931-942
Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplificationby fluorescence in situ hybridization in primary human breast cancers
Authors: Janocko, LE Brown, KA Smith, CA Gu, LP Pollice, AA Singh, SG Julian, T Wolmark, N Sweeney, L Silverman, JF Shackney, SE
Citation: Le. Janocko et al., Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplificationby fluorescence in situ hybridization in primary human breast cancers, CYTOMETRY, 46(3), 2001, pp. 136-149
Tamoxifen and breast cancer incidence among women with inherited mutationsin BRCA1 and BRCA2 - National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
Authors: King, MC Wieand, S Hale, K Lee, M Walsh, T Owens, K Tait, J Ford, L Dunn, BK Costantino, J Wickerham, L Wolmark, N Fisher, B
Citation: Mc. King et al., Tamoxifen and breast cancer incidence among women with inherited mutationsin BRCA1 and BRCA2 - National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial, J AM MED A, 286(18), 2001, pp. 2251-2256
Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience
Authors: Fisher, B Land, S Mamounas, E Dignam, J Fisher, ER Wolmark, N
Citation: B. Fisher et al., Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience, SEMIN ONCOL, 28(4), 2001, pp. 400-418
National Surgical Adjuvant Breast and Bowel Project trials in colon cancer
Authors: Wolmark, N Colangelo, L Wieand, S
Citation: N. Wolmark et al., National Surgical Adjuvant Breast and Bowel Project trials in colon cancer, SEMIN ONCOL, 28(1), 2001, pp. 9-13
Fifteen-year prognostic discriminants for invasive breast carcinoma - National Surgical Adjuvant Breast and Bowel Project Protocol-06
Authors: Fisher, ER Anderson, S Tan-Chiu, E Fisher, B Eaton, L Wolmark, N
Citation: Er. Fisher et al., Fifteen-year prognostic discriminants for invasive breast carcinoma - National Surgical Adjuvant Breast and Bowel Project Protocol-06, CANCER, 91(8), 2001, pp. 1679-1687
Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer
Authors: Julian, TB Patel, N Dusi, D Olson, P Nathan, G Jasnosz, K Isaacs, G Wolmark, N
Citation: Tb. Julian et al., Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer, AM J SURG, 182(4), 2001, pp. 407-410
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
Authors: Wolmark, N Wieand, HS Hyams, DM Colangelo, L Dimitrov, NV Romond, EH Wexler, M Prager, D Cruz, AB Gordon, PH Petrelli, NJ Deutsch, M Mamounas, E Wickerham, DL Fisher, ER Rockette, H Fisher, B
Citation: N. Wolmark et al., Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02, J NAT CANC, 92(5), 2000, pp. 388-396
HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15
Authors: Paik, S Bryant, J Tan-Chiu, E Yothers, G Park, C Wickerham, DL Wolmark, N
Citation: S. Paik et al., HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15, J NAT CANC, 92(24), 2000, pp. 1991-1998
Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: Evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas
Authors: Smith, CA Pollice, AA Gu, LP Brown, KA Singh, SG Janocko, LE Johnson, R Julian, T Hyams, D Wolmark, N Sweeney, L Silverman, JF Shackney, SE
Citation: Ca. Smith et al., Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: Evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas, CLIN CANC R, 6(1), 2000, pp. 112-126
The logic of evidence - In reply
Authors: Wieand, S Wolmark, N
Citation: S. Wieand et N. Wolmark, The logic of evidence - In reply, J CL ONCOL, 18(4), 2000, pp. 942-942
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project
Authors: Dignam, JJ Colangelo, L Tian, W Jones, J Smith, L Wickerham, DL Wolmark, N
Citation: Jj. Dignam et al., Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project, J NAT CANC, 91(22), 1999, pp. 1933-1940
Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: A re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses
Authors: Thirion, P Wolmark, N Haddad, E Buyse, M Piedbois, P
Citation: P. Thirion et al., Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: A re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses, ANN ONCOL, 10(11), 1999, pp. 1317-1320
Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' c colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04)
Authors: Mamounas, E Wieand, S Wolmark, N Bear, HD Atkins, JN Song, K Jones, J Rockette, H
Citation: E. Mamounas et al., Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' c colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04), J CL ONCOL, 17(5), 1999, pp. 1349-1355
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25
Authors: Fisher, B Anderson, S DeCillis, A Dimitrov, N Atkins, JN Fehrenbacher, L Henry, PH Romond, EH Lanier, KS Davila, E Kardinal, CG Laufman, L Pierce, HI Abramson, N Keller, AM Hamm, JT Wickerham, DL Begovic, M Tan-Chiu, E Tian, W Wolmark, N
Citation: B. Fisher et al., Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25, J CL ONCOL, 17(11), 1999, pp. 3374-3388
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from national surgical adjuvant breast and bowel project C-04
Authors: Wolmark, N Rockette, H Mamounas, E Jones, J Wieand, S Wickerham, DL Bear, HD Atkins, JN Dimitrov, NV Glass, AG Fisher, ER Fisher, B
Citation: N. Wolmark et al., Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from national surgical adjuvant breast and bowel project C-04, J CL ONCOL, 17(11), 1999, pp. 3553-3559
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
Authors: Fisher, B Dignam, J Wolmark, N Wickerham, DL Fisher, ER Mamounas, E Smith, R Begovic, M Dimitrov, NV Margolese, RG Kardinal, CG Kavanah, MT Fehrenbacher, L Oishi, RH
Citation: B. Fisher et al., Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial, LANCET, 353(9169), 1999, pp. 1993-2000
Long-term follow-up post-cryosurgery in a sheep breast model
Authors: Rabin, Y Julian, TB Olson, P Taylor, MJ Wolmark, N
Citation: Y. Rabin et al., Long-term follow-up post-cryosurgery in a sheep breast model, CRYOBIOLOGY, 39(1), 1999, pp. 29-46
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17 - Intraductal carcinoma
Authors: Fisher, ER Dignam, J Tan-Chiu, E Costantino, J Fisher, B Paik, S Wolmark, N
Citation: Er. Fisher et al., Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17 - Intraductal carcinoma, CANCER, 86(3), 1999, pp. 429-438
Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National surgical adjuvant breast and bowel project protocol C-05
Authors: Wolmark, N Bryant, J Smith, R Grem, J Allegra, C Hyams, D Atkins, J Dimitrov, N Oishi, R Prager, D Fehrenbacher, L Romond, E Colangelo, L Fisher, B
Citation: N. Wolmark et al., Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National surgical adjuvant breast and bowel project protocol C-05, J NAT CANC, 90(23), 1998, pp. 1810-1816
Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project
Authors: Dignam, JJ Bryant, J Wieand, HS Fisher, B Wolmark, N
Citation: Jj. Dignam et al., Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project, CONTR CL TR, 19(6), 1998, pp. 575-588
Evaluation of post cryosurgery injury in a sheep breast model using the vital stain 2,3,5-triphenyltetrazolium chloride
Authors: Rabin, Y Julian, TB Olson, P Taylor, MJ Wolmark, N
Citation: Y. Rabin et al., Evaluation of post cryosurgery injury in a sheep breast model using the vital stain 2,3,5-triphenyltetrazolium chloride, CRYO-LETT, 19(4), 1998, pp. 255-262
Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy
Authors: Logan, TF Banner, B Rao, U Ernstoff, MS Wolmark, N Whiteside, TL Miketic, L Kirkwood, JM
Citation: Tf. Logan et al., Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy, CLIN EXP IM, 114(3), 1998, pp. 347-354
Risultati: 1-25 |